Skip to main content
SpringerLink
Log in

Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using bothμ1 andδ opioid receptors

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The aim of this study is to analyze further the opioid receptor subtypes involved in the augmentation of behavioral activity after dopamine depletion in the nucleus accumbens of rats. Initially, the opioid receptors involved in the augmentation of locomotion produced by endogenous opioids were evaluated by microinjection of kelatorphan, an inhibitor of proteolytic enzymes that inactivates enkephalin, with or without specific antagonists forμ 1 orδ-opioid receptors, naloxonazine or naltrindole, respectively. Kelatorphan produced a dose-dependent increase in horizontal photocell counts and vertical movements. At all doses examined the behavioral response was augmented in rats sustaining accumbal dopamine lesions. The augmentation in dopamine-depleted rats was partially blocked by naloxonazine or naltrindole. Since the motor stimulant response to intra-accumbens microinjection of theδ-opioid agonist, [d-penicillamine2,5]-enkephalin, was not augmented in a previous study, we tested the behavioral response to a new endogenousδ-opioid agonist, [d-Ala2] deltorphin I. The locomotor response to deltorphin was slightly augmented in dopamine-depleted rats. These data suggest that the augmentation in the motor response elicited by endogenous opioids after dopamine lesions in the nucleus accumbens involves bothμ 1 andδ-opioid receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Austin MC, Kalivas PW (1990) Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum. J Pharmacol Exp Ther 252:1370–1377

    CAS  PubMed  Google Scholar 

  • Bouboutou R, Waksman G, Devin J, Foiurnie-Zaluski M-C, Roques BP (1984) Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes. Life Sci 35:1023–1030

    Article  CAS  PubMed  Google Scholar 

  • Childers SR (1988) Opiate-inhibited adenylate cyclase in rat brain membranes depleted of Gs-stimulated adenylate cyclase. J Neurochem 50:543–553

    CAS  PubMed  Google Scholar 

  • Churchill L, Kalivas PW (1992) Dopamine depletion produces augmented behavioral responses to a mu, but not a delta-opioid agonist in the nucleus accumbens: lack of a role for receptor upregulation. Synapse 11:47–57

    Article  CAS  PubMed  Google Scholar 

  • Churchill L, Austin MC, Kalivas PW (1992) Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens. Psychopharmacology 108:141–146

    Article  CAS  PubMed  Google Scholar 

  • Clarke PBS, Jakubovic A, Fibiger HC (1988) Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions ofd-amphetamine and apomorphine. Psychopharmacology 96:511–520

    Article  CAS  PubMed  Google Scholar 

  • Cooper DMF, Londos C, Gill DL, Rodbell M (1986) Opiate-receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes. J Neurochem 38:1164–1167

    Google Scholar 

  • Cunningham ST, Kelley AE (1992) Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward. Brain Res 588:104–114

    CAS  PubMed  Google Scholar 

  • Dauge V, Rossignol P, Roques BP (1988) Comparison of the behavioral effects induced by administration in rat nucleus accumbens or nucleus caudatus of selectiveμ andδ opioid peptides or kelatorphan, an inhibitor of enkephalin-degrading enzymes. Psychopharmacology 96:343–352

    Article  CAS  PubMed  Google Scholar 

  • Delfs JM, Schreiber L, Kelley AE (1990) Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 10:303–310

    CAS  PubMed  Google Scholar 

  • Fallon JH, Moore RY (1978) Catecholamine innervation of basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and striatum. J Comp Neurol 180:545–580

    CAS  PubMed  Google Scholar 

  • Fink JS, Smith GP (1980) Mesolimbocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats. Brain Res 199:359–385

    CAS  PubMed  Google Scholar 

  • Gentleman S, Parenti M, Neff NH, Pert CB (1983) Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum. Cell Mol Neurobiol 3:17–26

    Article  CAS  PubMed  Google Scholar 

  • Gerfen CR, Herkenham M, Thibault J (1987) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915–3934

    CAS  PubMed  Google Scholar 

  • Jiang Q, Mosberg HI, Porreca F (1990) Antinociceptive effects of [d-Ala2]deltorphin II, a highly selectiveδ agonist in vivo. Life Sci 47:PL43-PL47

    Article  CAS  Google Scholar 

  • Jiang Q, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F (1991) Differential antagonism of opioid delta antinociception by [d-Ala2,Leu5,Cys6]enkephalin and naltrindole 5′-isothiocyanate: evidence for delta receptor subtypes. J Pharmacol Exp Ther 257:1069–1075

    CAS  PubMed  Google Scholar 

  • Jones DNC, Bowen WD, Portoghese PS, Holtzman SG (1994)δ-Opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. Eur J Pharmacol 249:167–177

    Google Scholar 

  • Kalivas PW, Bronson M (1985) Mesolimbic dopamine lesions produce an augmented response to enkephalin. Neuropharmacology 24:931–936

    Article  CAS  PubMed  Google Scholar 

  • Kalivas PW, Widerlov E, Stanley D, Breese GR, Prange AJ Jr (1983) Enkephalin action on the mesolimbic dopamine system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther 227:229–237

    CAS  PubMed  Google Scholar 

  • Kalivas PW, Churchill L, Klitenick MA (1993) The circuitry mediating the translation of motivational stimuli into adaptive motor responses. In: Kalivas PW, Barnes CD (eds) Limbic motor circuits and neuropsychiatry. CRC Press, Boca Raton, Fla., pp 237–287

    Google Scholar 

  • Kelly PH, Iversen SD (1976) Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45–56

    Article  CAS  PubMed  Google Scholar 

  • Koob GF, Stinus L, le Moal M (1981) Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behav Brain Res 3:341–359

    Article  CAS  PubMed  Google Scholar 

  • Lacey MG, Mercuri NB, North RA (1987) Dopamine acts at D2 receptors to increase potassium conductance in neurones of the rat substantia nigra. J Physiol (Lond) 392:397–416

    CAS  PubMed  Google Scholar 

  • Law PY, Wu J, Koehler JE, Loh HH (1981) Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase. J Neurochem 36:1834–1846

    CAS  PubMed  Google Scholar 

  • Le Moine C, Normand E, Guitteny AF, Fouque B, Teoule R, Bloch B (1990) Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 87:230–234

    PubMed  Google Scholar 

  • Ling G.S.F, Simantov R, Clark JA, Pasternak GW (1986) Naloxonazine actions in vivo. Eur J Pharmacol 129:33–38

    Article  CAS  PubMed  Google Scholar 

  • Maldonado R, Dauge V, Feger J, Roques BP (1990) Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioral responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats. Neuropharmacology 29:215–223

    Article  CAS  PubMed  Google Scholar 

  • Mattia A, Vanderah T, Mosberg HI, Porreca F (1991) Lack of antinociceptive cross-tolerance between [d-Pen2,d-Pen5] enkephalin and [d-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. J Pharmacol Exp Ther 258:583–587

    CAS  PubMed  Google Scholar 

  • Milliken GA, Johnson DE (1984) Analysis of messy data, vol. I: Designed experiments. Lifetime Learning Publications, Belmont, Calif.

    Google Scholar 

  • Negri L, Noviello V, Angelucci F (1991) Behavioral effects of deltorphins in rats. Eur J Pharmacol 209:163–168

    Article  CAS  PubMed  Google Scholar 

  • North RA, Williams JT, Suprenant A, Christie MJ (1987)μ andδ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 84:5487–5491

    CAS  PubMed  Google Scholar 

  • Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New York

    Google Scholar 

  • Pellegrino LK, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum Press, New York

    Google Scholar 

  • Pert A, Sivit C (1977) Neuroanatomical focus for morphine and enkephalin-induced hypermotility. Nature 265:645–647

    Article  CAS  PubMed  Google Scholar 

  • Pickel VM, Chan J, Sesack SR (1992) Cellular basis for interactions between catecholaminergic afferents and leu-enkephalin-like immunoreactivity in rat caudate-putamen. J Neurosci Res 31:212–230

    Article  CAS  PubMed  Google Scholar 

  • Pijnenburg AJJ, Honig WMM, Van der Heyden JAM, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45–58

    Article  CAS  PubMed  Google Scholar 

  • Porreca F, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI (1992) Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther 263:147–152

    CAS  PubMed  Google Scholar 

  • Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T (1994) Pharmacological characterization of the clonedκ-,δ-, andμ-opioid receptors. Mol Pharmacol 45:330–334

    CAS  PubMed  Google Scholar 

  • Sofuoglu M, Portoghese PS, Takemori AE (1991) Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 257:676–680

    CAS  PubMed  Google Scholar 

  • Stevens KE, Mickley GA, McDermott LJ (1986) Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse. Pharmacol Biochem Behav 24:1739–1747

    Article  CAS  PubMed  Google Scholar 

  • Stinus L, Winnock M, Kelley AE (1985) Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioral supersensitivity to opiates. Psychopharmacology 85:323–328

    Article  CAS  PubMed  Google Scholar 

  • Swanson LW (1982) The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321–353

    Article  CAS  PubMed  Google Scholar 

  • Swerdlow NR, Vaccarino FJ, Koob GF (1985) Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacol Biochem Behav 23:499–501

    CAS  PubMed  Google Scholar 

  • Tooyama I, Abe H, Renda T, Erspamer V, Kimura H (1993) [d-Ala2] deltorphin I like immunoreactivity in the adult rat brain: immunohistochemical localization. Proc Natl Acad Sci USA 90:9635–9639

    CAS  PubMed  Google Scholar 

  • Vanderah T, Takemore AE, Sultana M, Portoghese PS, Mosberg HI, Hruby VJ, Haaseth RC, Matsunaga TO, Porreca F (1994) Interaction of [d-Pen2,d-Pen5]enkephalin and [d-Ala2,Glu4]deltorphin withδ-opioid receptor subtypes in vivo. Eur J Pharmacol 252:133–137

    Article  CAS  PubMed  Google Scholar 

  • Vezina P, Kalivas PW, Stewart J (1987) Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the VTA but not to the nucleus accumbens. Brain Res 417:51–58

    Article  CAS  PubMed  Google Scholar 

  • Waksman G, Bouboutou R, Devin J, Bourgoin S, Cesselin F, Hamon M, Fourni-Zaluski M-C, Roques BP (1985) In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Eur J Pharmacol 117:233–243

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology, Washington State University, Pullman, Washington, USA

    L. Churchill & P. W. Kalivas

  2. Department de Pharmacochimie Moleculaire et Structurale, U266 INSERM, URA D1500 CNRS, Faculte de Pharmacie, Paris, France

    B. P. Roques

Authors
  1. L. Churchill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. P. Roques
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. W. Kalivas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Churchill, L., Roques, B.P. & Kalivas, P.W. Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using bothμ1 andδ opioid receptors. Psychopharmacology 120, 347–355 (1995). https://doi.org/10.1007/BF02311183

Download citation

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02311183

Key words

Search

Navigation